Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: A case report and review of literature | Journal of Medical Case Reports BioMed Central Open Access Case report Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands A case report and review of literature Salvatore Grisanti 1 Vito Amoroso1 Michela Buglione2 Anna Rosati3 Roberto Gatta2 Claudio Pizzocaro4 Vittorio D Ferrari1 and Giovanni Marini1 Address Department of Medical Oncology Azienda Spedali Civili Brescia Italy 2Department of Radiotherapy Oncology University of Brescia Brescia Italy 3Department of Neurology University of Brescia Brescia Italy and 4Department of Nuclear Medicine University of Brescia Brescia Italy Email Salvatore Grisanti - Vito Amoroso - vitoamoroso@ Michela Buglione - buglione@ Anna Rosati - annarosati@ Roberto Gatta - robgat74@ Claudio Pizzocaro - Vittorio D Ferrari - vittoriodf59@ Giovanni Marini - bscivile@ Corresponding author Published 30 September 2008 Received 28 January 2008 Journal of Medical Case Reports 2008 2 320 doi 1752-1947-2-320 Accepted 30 September 2008 This article is available from http content 2 1 320 2008 Grisanti et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Introduction Patients with metastatic mucoepidermoid carcinoma of salivary glands have a poor outcome. The epidermal growth factor receptor protein is overexpressed in approximately 70 of mucoepidermoid carcinoma patients and may represent a therapeutic target. However whether treatment with anti-epidermal growth factor receptor agents is effective is unclear and clinical .
